by PVA_Admin | Jun 15, 2023 | 2023 Press Release, Press Release
JCRI-ABTS and USMI Reports Statistically Significant Results of the Canady Helios Cold Plasma Phase 1 Clinical Trial on Patients with Stage 4 and Recurrent Advanced Solid Tumors TAKOMA PARK, Md.–(BUSINESS WIRE)—June 15, 2023 – The Jerome Canady Research...
by PVA_Admin | Sep 21, 2022 | 2022 Press Release, Press Release
2022 US Medical Innovations Raises $10.2 M in Private Placement TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a subsidiary of US Patent Innovations, LLC, announced today it has secured a $10.2 million private placement deal from...
by PVA_Admin | Jun 16, 2022 | Cold Plasma Publications, Publications
Canady Cold Helios Plasma Reduces Soft Tissue Sarcoma Viability by Inhibiting Proliferation, Disrupting Cell Cycle, and Inducing Apoptosis: A Preliminary Report Lawan Ly, Xiaoqian Cheng, Saravana R. K. Murthy, Olivia Z. Jones, Taisen Zhuang, Steven Gitelis, Alan T....
by PVA_Admin | May 12, 2022 | 2022 Press Release, Press Release
JCRI – ABTS and USMI to Present a Two-year Follow-up of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at Israeli Society of Surgical Oncology TAKOMA PARK, Md.–(BUSINESS WIRE)–Jerome Canady Research Institute...
by PVA_Admin | May 5, 2022 | Cold Plasma Publications, Publications
The Granger Causal Effects of Canady Helios Cold Plasma on the Inhibition of Breast Cancer Cell Proliferation Annisa Elbedour, Xiaoqian Cheng, Saravana R. K. Murthy, Taisen Zhuang, Lawan Ly, Olivia Jones, Giacomo Basadonna, Michael Keidar, and Jerome Canady Cold...
